Wednesday, March 25, 2026
StockstToday.com Logo
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
StocksToday.com Logo
No Result
View All Result
Home Breaking News

Utz Brands Analyst Scoreboard Recent Ratings and Price Targets

Elaine Mendonca by Elaine Mendonca
March 1, 2024
in Breaking News
0
Finance_Assets (3)
0
SHARES
9
VIEWS
Share on FacebookShare on Twitter

Utz Brands Analyst Scoreboard Update

In the last three months, analysts have shared a range of perspectives on Utz Brands (NYSE: UTZ), with varying ratings from bullish to bearish. Here is a breakdown of recent ratings and insights:

Total Ratings:
– Bullish: 3
– Somewhat Bullish: 2
– Indifferent: 1
– Somewhat Bearish: 0
– Bearish: 0

Latest 30 Days:
– Bullish: 1
– Somewhat Bullish: 0
– Indifferent: 1
– Somewhat Bearish: 0
– Bearish: 0

12-Month Price Targets:
– Average Target: $19.42
– High Estimate: $20.50
– Low Estimate: $18.00

Recent actions by key analysts include:
– Matt McGinley from Needham upgraded the rating to Buy with a price target of $20.50.
– Brian Holland from DA Davidson maintained a Neutral rating with a price target of $20.00.
– John Baumgartner from Mizuho issued a Buy rating with a price target of $19.00.
– Michael Lavery from Piper Sandler upgraded the rating to Overweight with a price target of $18.00.
– Nik Modi from RBC Capital upgraded the rating to Outperform with a price target of $19.00.

Analysts’ adjustments reflect their evaluations of Utz Brands’ outlook in response to market conditions and company performance, highlighting changing dynamics in the industry.

UTZ Stock Analysis: Price Decline on March 1, 2024 – What Investors Need to Know

On March 1, 2024, UTZ stock experienced a slight decline in its performance. The stock closed at $17.69, which was a decrease of $0.65 or 3.54% from the previous market close. Additionally, in after-hours trading, the stock dropped a further $0.26. Despite the decrease in price on this particular day, UTZ is still trading near the top of its 52-week range and above its 200-day simple moving average. This indicates that the stock has been performing well over a longer period of time, even though it experienced a slight dip on March 1st. Investors may be monitoring UTZ closely to see if this decline is a temporary fluctuation or the start of a larger downward trend. It is important to consider the overall market conditions and any specific news or events that may be impacting UTZ’s stock performance. As with any investment, it is essential for investors to conduct thorough research and analysis before making any decisions. Keeping track of price movements, technical indicators, and market trends can help investors make informed choices about their investments in UTZ or any other stock.

UTZ Brands, Inc. Financial Performance Review: Mixed Results on March 1, 2024

On March 1, 2024, UTZ Brands, Inc. (UTZ) had a mixed performance in terms of its financials. According to data from CNN Money, the company reported total revenue of $1.41 billion for the past year, which represents a 19.28% increase compared to the previous year. However, total revenue remained flat at $371.85 million for the last quarter. In terms of net income, UTZ reported a net loss of $392,000 for the past year, which is a significant decrease of 101.94% compared to the previous year. On the other hand, the company reported a net income of $15.99 million for the last quarter, marking a substantial increase of 487.8% compared to the previous quarter. Earnings per share (EPS) for UTZ also saw a mixed performance. The company reported an EPS of -$0.00 for the past year, which is a decrease of 101.97% compared to the previous year. However, EPS improved to $0.19 for the last quarter, representing an increase of 476.62% compared to the previous quarter. Overall, UTZ’s stock performances on March 1, 2024, reflect a company that has seen both positive and negative trends in its financial metrics. The increase in total revenue over the past year is a positive sign, but the significant decrease in net income for the same period raises concerns. The substantial increase in net income and EPS for the last quarter is a promising development, but investors may want to closely monitor UTZ’s financial performance in the coming quarters to assess its long-term sustainability.

Tags: UTZ
Elaine Mendonca

Elaine Mendonca

Related Posts

NFT projects
Breaking News

The Impact of TikToks Fate on USChina Relations and American Tech Giants

March 16, 2024
Businesses finance
Breaking News

Blackstone Strategic Credit 2027 Term Fund BGB Announces Monthly Dividend of 93 Cents per Share

March 15, 2024
Healthcare-sector
Breaking News

Analyzing Short Interest in Molina Healthcare Inc MOH

March 15, 2024
Next Post

Empowering the Next Generation enCore Energys Education Society and Scholarship Programs

Global supply chain

Goldman Sachs Analyst Bonnie Herzog Issues Sell Rating on Clorox

DVY stock news

Analysts Bullish on GoodRx Holdings Inc Following Strong Q4 FY23 Results

Recommended

Finance_ People trading stocks

Analyst Upgrades QuinStreet Stock to Strong Buy with Increased Price Target

2 years ago
Trimble Stock

Trimble Stock: A Study in Contrasting Signals

7 months ago
Regency Centers Stock

Regency Centers Stock: Strong Dividend Hike Meets Market Skepticism

5 months ago
Cardinal Health Stock

Cardinal Health Shares Test Key Support Level Amid Sector Uncertainty

6 months ago

Categories

  • AI & Quantum Computing
  • Analysis
  • Analyst Ratings
  • Asian Markets
  • Automotive & E-Mobility
  • Banking & Insurance
  • Bitcoin
  • Blockchain
  • Bonds
  • Breaking News
  • Business & Industry Trends
  • Cannabis
  • Chemicals
  • Commodities
  • Consumer & Luxury
  • Crypto Stocks
  • Cryptocurrency
  • Cyber Security
  • DAX
  • Defense & Aerospace
  • Dividends
  • Dow Jones
  • E-Commerce
  • Earnings
  • Emerging Markets
  • Energy & Oil
  • ETF
  • Ethereum & Altcoins
  • European Markets
  • Forex
  • Gaming & Metaverse
  • Gold & Precious Metals
  • Healthcare
  • Hydrogen
  • Index
  • Industrial
  • Insider Trading
  • IPOs
  • Market Commentary
  • Market News
  • MDAX & SDAX
  • Mergers & Acquisitions
  • Nasdaq
  • Newsletter
  • Penny Stocks
  • Pharma & Biotech
  • Real Estate & REITs
  • Renewable Energy
  • S&P 500
  • Semiconductors
  • Space
  • Stock Picks
  • Stock Targets
  • Stocks
  • TecDAX
  • Tech & Software
  • Telecommunications
  • Trading & Momentum
  • Turnaround
  • Uncategorized
  • Value & Growth

Topics

Adobe Alibaba Alphabet Amazon AMD Apple ASML BioNTech Bitcoin Bloom Energy Broadcom Coinbase D-Wave Quantum Eli Lilly Fiserv IBM Intel Kraft Heinz Marvell Technology META Micron Microsoft MP Materials MSCI World ETF Newmont Mining NIO Novo Nordisk Nvidia Ocugen Oracle Palantir PayPal Plug Power QuantumScape Realty Income Robinhood Rocket Lab USA Salesforce Strategy Synopsys Tesla Tilray Unitedhealth Uranium Energy Viking Therapeutics
No Result
View All Result

Highlights

Gossamer Bio’s Pivotal FDA Meeting Looms in June 2026

Semiconductor Sector Faces Supply Chain Strain Amid Helium Shortage Concerns

Regulatory Scrutiny and Price Wars Threaten Fair Isaac’s Dominance

Figma Embraces Third-Party AI to Power Its Design Ecosystem

BioNano Genomics Stock: A Tale of Operational Gains and Revenue Headwinds

Humacyte Shares Hit Record Low Amid Capital Raise and Strategic Shifts

Trending

Coherent Stock
AI & Quantum Computing

Coherent Stock Accelerates Toward New Highs on Key Breakthroughs

by Kennethcix
March 25, 2026
0

Shares of Coherent surged this week, propelled by a landmark technological demonstration and significant corporate developments that...

Corning Stock

Corning’s Strategic Alliance with Meta Fuels Investor Confidence

March 25, 2026
Dell Stock

Dell’s Quantum Security Push Amidst AI-Driven Growth

March 25, 2026
Gossamer Bio Stock

Gossamer Bio’s Pivotal FDA Meeting Looms in June 2026

March 25, 2026
SOXX ETF Stock

Semiconductor Sector Faces Supply Chain Strain Amid Helium Shortage Concerns

March 25, 2026

StocksToday.com is your one-stop destination for the latest stock news and analysis. We provide in-depth coverage of the stock market, including market news, company news, sector news, IPO news, investment strategies, personal finance, international markets, and more.

Follow us on social media:

Recent News

  • Coherent Stock Accelerates Toward New Highs on Key Breakthroughs
  • Corning’s Strategic Alliance with Meta Fuels Investor Confidence
  • Dell’s Quantum Security Push Amidst AI-Driven Growth

Category

  • About
  • Advertise
  • Careers
  • Contact
  • Imprint
  • Privacy Policy
  • Terms of Service

© 2023 StocksToday.com

No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing

© 2023 StocksToday.com